DOP2009000102A - Anticuerpos del agonista trkb y usos de los mismos - Google Patents

Anticuerpos del agonista trkb y usos de los mismos

Info

Publication number
DOP2009000102A
DOP2009000102A DO2009000102A DO2009000102A DOP2009000102A DO P2009000102 A DOP2009000102 A DO P2009000102A DO 2009000102 A DO2009000102 A DO 2009000102A DO 2009000102 A DO2009000102 A DO 2009000102A DO P2009000102 A DOP2009000102 A DO P2009000102A
Authority
DO
Dominican Republic
Prior art keywords
antibodies
same
trkb
agonist
agonist trkb
Prior art date
Application number
DO2009000102A
Other languages
English (en)
Inventor
Yan Wang
Steven Bruce Cohen
Marc Nasoff
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of DOP2009000102A publication Critical patent/DOP2009000102A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DO2009000102A 2006-11-09 2009-05-08 Anticuerpos del agonista trkb y usos de los mismos DOP2009000102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85816906P 2006-11-09 2006-11-09

Publications (1)

Publication Number Publication Date
DOP2009000102A true DOP2009000102A (es) 2010-10-31

Family

ID=39365312

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2009000102A DOP2009000102A (es) 2006-11-09 2009-05-08 Anticuerpos del agonista trkb y usos de los mismos

Country Status (27)

Country Link
US (1) US20100150914A1 (es)
EP (1) EP2087007A2 (es)
JP (1) JP2010509354A (es)
KR (1) KR20090088896A (es)
CN (1) CN101573381A (es)
AR (1) AR063640A1 (es)
AU (1) AU2007316418A1 (es)
BR (1) BRPI0719000A2 (es)
CA (1) CA2669205A1 (es)
CL (1) CL2007003236A1 (es)
CO (1) CO6180432A2 (es)
CR (1) CR10779A (es)
DO (1) DOP2009000102A (es)
EA (1) EA200970469A1 (es)
EC (1) ECSP099392A (es)
IL (1) IL198468A0 (es)
MA (1) MA30922B1 (es)
MX (1) MX2009004881A (es)
NI (1) NI200900081U (es)
NO (1) NO20092217L (es)
PE (1) PE20081168A1 (es)
RU (1) RU2009121641A (es)
SM (1) SMAP200900040A (es)
TN (1) TN2009000181A1 (es)
TW (1) TW200829270A (es)
WO (1) WO2008058127A2 (es)
ZA (1) ZA200902943B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2214706A1 (en) * 2007-10-23 2010-08-11 Novartis AG Use of trkb antibodies for the treatment of respiratory disorders
PE20091326A1 (es) 2008-01-17 2009-09-18 Irm Llc Anticuerpos anti-trkb mejorados
EP2408455B1 (en) * 2009-03-20 2014-06-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Inhibitors of cathepsin S for prevention or treatment of obesity-associated disorders
GB2491106A (en) * 2011-05-18 2012-11-28 Univ Basel Antibodies against tropomyosin-related kinase B receptors
EP2788027A2 (en) * 2011-12-09 2014-10-15 Novo Nordisk A/S Glp-1 agonists
CN102944674B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法
CN102901815B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体816/817位酪氨酸位点活性的ELISA试剂盒及其使用方法
ES2936810T3 (es) 2014-05-16 2023-03-22 Pfizer Anticuerpos biespecíficos con interfaces CH1-CL de ingeniería
CN104524568B (zh) * 2015-01-08 2018-04-20 中国人民解放军第二军医大学 一种治疗肥胖症的药物组合物及其应用
KR20180037994A (ko) * 2015-07-28 2018-04-13 오토노미, 인코포레이티드 TrkB 또는 TrkC 아고니스트 조성물 및 귀 병태의 치료 방법
JP7039468B2 (ja) 2015-11-17 2022-03-22 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 神経およびその他の障害の処置のための結合アゴニスト
US9914781B1 (en) 2016-11-08 2018-03-13 Glaxosmithkline Intellectual Property Development Limited Binding agonist for treatment of neurological and other disorders
SG11201909708VA (en) * 2017-04-21 2019-11-28 Mellitus Llc Methods and antibodies for diabetes-related applications
US10793634B2 (en) 2017-06-09 2020-10-06 Boehringer Ingelheim International Gmbh Anti-TrkB antibodies
US11066474B2 (en) * 2017-11-30 2021-07-20 Regeneron Pharmaceuticals, Inc. Anti-TrkB monoclonal antibodies and methods of use
EP3759145A4 (en) 2018-02-26 2022-03-09 Minerva Biotechnologies Corporation DIAGNOSTIC METHODS USING ANTI-MUC1* ANTIBODIES
CN110818797B (zh) * 2018-08-09 2022-11-04 东莞市朋志生物科技有限公司 一种抗人ca153蛋白的重组抗体
EP4232474A1 (en) 2020-10-21 2023-08-30 Boehringer Ingelheim International GmbH Bispecific anti-vegf and anti-trkb binding molecules for the treatment of eye diseases
WO2023125485A1 (en) * 2021-12-28 2023-07-06 4B Technologies (Beijing) Co., Limited TrkB ANTIBODY AND APPLICATION THEREOF

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DE69534347T2 (de) 1994-01-31 2006-05-24 Trustees Of Boston University, Boston Bibliotheken aus Polyklonalen Antikörpern
US5601820A (en) * 1994-07-07 1997-02-11 Children's Hospital Of Philadelphia Compositions and methods of making and using human full length TRK-B
GT200600240A (es) * 2005-06-06 2007-03-14 Anticuerpos monoclonales anti-trkb y usos de los mismos
CN101400367A (zh) * 2006-02-02 2009-04-01 瑞纳神经科学公司 施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法
JP2009525319A (ja) * 2006-02-02 2009-07-09 ライナット ニューロサイエンス コーポレイション ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法

Also Published As

Publication number Publication date
JP2010509354A (ja) 2010-03-25
EA200970469A1 (ru) 2010-04-30
AU2007316418A1 (en) 2008-05-15
CO6180432A2 (es) 2010-07-19
WO2008058127A9 (en) 2008-08-21
EP2087007A2 (en) 2009-08-12
MX2009004881A (es) 2009-05-21
KR20090088896A (ko) 2009-08-20
ZA200902943B (en) 2010-05-26
MA30922B1 (fr) 2009-11-02
SMAP200900040A (it) 2010-01-19
CR10779A (es) 2009-07-03
CL2007003236A1 (es) 2008-06-13
IL198468A0 (en) 2011-08-01
TW200829270A (en) 2008-07-16
RU2009121641A (ru) 2010-12-20
NI200900081U (es) 2010-03-16
WO2008058127A3 (en) 2008-10-02
BRPI0719000A2 (pt) 2013-12-10
CA2669205A1 (en) 2008-05-15
WO2008058127A2 (en) 2008-05-15
ECSP099392A (es) 2009-07-31
AR063640A1 (es) 2009-02-04
PE20081168A1 (es) 2008-09-22
NO20092217L (no) 2009-06-09
CN101573381A (zh) 2009-11-04
TN2009000181A1 (en) 2010-10-18
US20100150914A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
DOP2009000102A (es) Anticuerpos del agonista trkb y usos de los mismos
CR10743A (es) Derivados de azaadamantano y metodos de uso de los mismos
BRPI0815564A2 (pt) Anticorpos que inibem a dimerização de c-met e usos dos mesmos.
CR10847A (es) Compuesto heteromonociclico y uso del mismo
PL2502938T3 (pl) Przeciwciała i immunokoniugaty oraz ich zastosowanie
PT2474557E (pt) Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
BRPI0819909A2 (pt) anticorpos antimesotelina e usos dos mesmos
HRP20220755T3 (hr) Anti-gm-csf antitijela i njihova uporaba
ES2355534T8 (es) Derivados de isoquinolina e isoquinolinona sustituidos con cicloalquilamina.
BRPI0908980A2 (pt) Dispositivo de iluminação e dispositivo de exibição tendo o mesmo
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0822064A2 (pt) Dispositivos de imageamento fotoacústico e métodos de imageamento
BRPI0810524A2 (pt) Derivado de (aza)indol e uso do mesmo para propósitos médicos
EP2352816A4 (en) HUMAN TEMPORARY CELLS
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
DE602006020523D1 (de) Augenuntersuchungsgerät
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0814134A2 (pt) Dispositivo de iluminação e dispositivo de vídeo utilizando o mesmo
EP2038658A4 (en) TEST DEVICE
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
EP1989907A4 (en) VARIOUS IMPROVEMENTS OF THE HRPD SYSTEM
PL2256063T3 (pl) Urządzenie rozpylające oraz sposób użycia urządzenia rozpylającego
DE602005002131D1 (de) Prüfvorrichtung mit Anpassung des Prüfparameters
EP2209114A4 (en) ENCODER AND DECODER
BRPI0813457A2 (pt) Composto de organoenxofre contendo halogênio e uso do mesmo